| Trial ID: | L6896 |
| Source ID: | NCT01264497
|
| Associated Drug: |
Th9507
|
| Title: |
Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: TH9507
|
| Outcome Measures: |
Primary: Change from baseline in relative insulin response | Secondary: Change from baseline in glycosylated hemoglobin (HbA1c)|Change in mean daily serum glucose concentrations, Home blood glucose will be obtained four times per day (before breakfast, lunch, and dinner, and at bedtime) using a standard blood glucose meter|Changes in the number of dose adjustments per week for insulin and/or oral hypoglycemic agents|Number of subjects with a change in the control of diabetes
|
| Sponsor/Collaborators: |
Sponsor: Theratechnologies
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
55
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2002-02
|
| Completion Date: |
2002-11
|
| Results First Posted: |
|
| Last Update Posted: |
2010-12-21
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01264497
|
